Czechia – Medicinal products for the alimentary tract and metabolism – Inhibitory protonové pumpy - Pantoprazol i.v. aplikace II.

Institut Klinické A Experimentální Medicíny · Czech Republic government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$118,800
Est. Value
Active
Status

Opportunity Overview

Předmětem veřejné zakázky jsou pravidelné dodávky léčivého přípravků s obsahem účinné látky pantoprazol (ATC skupina A02BC02) pro intravenózní aplikaci určenou pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídky.

This Czech Republic Health Services opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyInstitut Klinické A Experimentální Medicíny
CountryCzech Republic
CategoryHealth Services
Estimated value$118,800
PublishedSeptember 18, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
Original languageCzech — members read it in their own language
Official sourceView original notice
Last verifiedOctober 04, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Czech Republic

Czechia – Various medicinal products – DNS-Průběžné dodávky léčivých přípravků s využitím Systému flexibilního tendrování léčiv (SFTL)
Czechia – Medical aids – Dodávky zdravotnických prostředků – senzory pro monitoraci glykémie
Czechia – Construction work – Z3 - Výstavba laboratorního pavilonu – modulární výstavba II.
Czechia – Cardiac therapy medicinal products – Kardiaka 15 - Acoramidis
Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Eculizumab IV.
Czechia – Immunosuppressive agents – Imunosupresiva - inhibitory TNF alfa II.
Czechia – Cardiac therapy medicinal products – Kardiaka 13 - Angiotenzin II.
Czechia – Renal dialysis consumables – ZP – Dodávky setů a roztoků pro kontinuální terapii ledvin II.

See every Czech Republic Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Czech Republic Health Services intelligence report in your inbox

A personalized report on Czech Republic Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.